❭ Research by medical division ❭ Cancer Medicine ❭ Institute for Cancer Research ❭ Dept. of Tumor Biology ❭ Metastasis Biology and Experimental Therapeutics [Mælandsmo]

Former members

Page visits: 975
Scroll to top

Home Dept. of Tumor Biology Metastasis Biology and Experimental Therapeutics [Mælandsmo]

  • Group members
  • Research interests
  • Publications
  • Links

Recent publications

Nunes-Xavier CE, Rodríguez-Ramos A, Pulido R (2026)
β-catenin at the crossroads of cancer and neurodevelopment
Trends Cancer (in press)
DOI 10.1016/j.trecan.2026.05.001, PubMed 42215419

Azimzade Y, Haugen MH, Kristensen VN, Frigessi A, Köhn-Luque A (2026)
Explainable machine learning-guided integrated multiomics analysis reveals macrophage-driven immune suppression in breast cancer
Nat Commun (in press)
DOI 10.1038/s41467-026-73617-9, PubMed 42185288

Ailte I, Chauhan SK, Prasmickaite L, Bassarova AV, Poissonnier A, Feenstra M, Nyakas M, Johannessen B, Ryder T, Hermann R, Frich L, Holth A, Inderberg EM, Jespersen H, Flørenes VA, Kyte JA, Mælandsmo GM, Egeland EV (2026)
CD38hiCD19dim cells in lymph nodes predict favorable prognosis in patients with stage III melanoma receiving adjuvant PD-1-blockade
Front Oncol, 16, 1815008
DOI 10.3389/fonc.2026.1815008, PubMed 42158424



More publications

Oslo University Hospital is a part of Southern and Eastern Norway Regional Health Authority.

Webmaster for research pages: Trond Olav Berg

Cookie policy

Accessibility statement (in Norwegian)